L-glutamine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases CD4/CD8 ratio
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.Finding“Analysis suggested Gln enriched nutrition support could effectively increase postoperative CD3+ T-cell (MD: 3.71; 95% CI: 2.57–4.85; P < 0.05) and CD4/CD8 ratio (MD: 0.27; 95% CI: 0.12–0.42; P < 0.05) of GI cancer patients.”
Quoted verbatim from Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Participants
- 322
- Population
- Surgical patients with gastrointestinal tumour given glutamine-enriched enteral or parenteral nutrition support, glutamine the only difference between arms per the review inclusion criteria; postoperative measurement; 5 pooled trials
Effect 0.27 mean difference, 95% CI 0.12 to 0.42
Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: a meta-analysis of randomized controlled trials.2015PMID:25591570Permalink
Keep reading
- Everything the graph holds on L-glutamine
- Every compound studied against CD4/CD8 ratio
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M0ZG9T8PGTRQWW57DQ49JGN7